longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DaVita

DVA

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 13.67, within the reasonable range, cheaper than 57.34% of the time in the past 3 years, and the industry ranks 9/74, the industry Median --.

13.67xP/E
$181.55Stock price
$13.28Earnings per share
13.67xP/E
Stock price$181.55Earnings per share$13.28

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
14.19x
Typical range
11.87x–16.21x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
07142128

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
CIUSCigna
11.56x12.54%$74.19B
FMSUSFresenius Medical Care
11.90x12.53%$12.96B
DVAUSDaVita
13.67x48.11%$11.58B
OPCHUSOption Care Health
16.78x17.91%$3.52B
AVAHUSAveanna Healthcare
11.18x31.53%$3.07B
MDUSPediatrix Medical
12.44x1.36%$2.18B
AMNUSAMN Healthcare Services
12.31x174.65%$1.29B
SRTAUSStrata Critical Medical
11.43x61.46%$459.59M
SBCUSSBC Medical
9.36x6.50%$458.70M
NIVFUSNewGenIvf
0.24x97.79%$2.39M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.